Sagimet Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:SGMT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Feb 26	SellUS$14,054	Elizabeth Rozek	Individual	2,622	US$5.36
10 Feb 26	SellUS$19,511	Eduardo Martins	Individual	3,640	US$5.36
10 Feb 26	SellUS$64,865	David Happel	Individual	12,101	US$5.36
10 Feb 26	SellUS$7,033	Thierry Chauche	Individual	1,312	US$5.36
21 Jul 25	SellUS$98,471	Elizabeth Rozek	Individual	10,780	US$9.13
21 Jul 25	SellUS$75,607	Eduardo Martins	Individual	8,277	US$9.13
21 Jul 25	SellUS$598,115	David Happel	Individual	65,478	US$9.13

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SGMT?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	536,276	0.868%
Public Companies	1,504,642	2.44%
Institutions	13,382,849	21.7%
General Public	46,328,040	75%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 91.8%.

Top Shareholders

Top 25 shareholders own 21.5% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.44%	Ascletis Pharma Inc.	1,504,642	US$11.6m	0%	no data
1.78%	Vanguard Capital Management, LLC	1,098,919	US$8.5m	0%	no data
1.62%	Woodline Partners LP	1,000,943	US$7.7m	0%	0.03%
1.56%	Marshall Wace LLP	966,253	US$7.4m	23.8%	0.01%
1.54%	Baker Bros. Advisors LP	952,996	US$7.3m	0%	0.04%
1.41%	Affinity Asset Advisors, LLC	868,020	US$6.7m	-24.4%	0.36%
1.4%	Millennium Management LLC	862,303	US$6.6m	46.9%	no data
1.3%	BlackRock, Inc.	799,943	US$6.2m	-1.72%	no data
1.17%	Hillhouse Investment Management, Ltd.	724,800	US$5.6m	0%	0.03%
1.01%	Renaissance Technologies LLC	625,469	US$4.8m	82.6%	0.01%
0.67%	D. E. Shaw & Co., L.P.	411,570	US$3.2m	-15.2%	no data
0.54%	CHI Advisors LLC	333,877	US$2.6m	-73.2%	0.91%
0.51%	Raymond James Financial, Inc.	317,550	US$2.4m	10.9%	no data
0.5%	Geode Capital Management, LLC	309,522	US$2.4m	4.62%	no data
0.49%	Hudson Bay Capital Management LP	303,223	US$2.3m	-0.41%	0.01%
0.49%	Bridgeway Capital Management, LLC	299,641	US$2.3m	0%	0.03%
0.48%	UBS Asset Management AG	293,934	US$2.3m	45.7%	no data
0.45%	David Happel	278,166	US$2.1m	6.47%	no data
0.44%	Dimensional Fund Advisors LP	271,217	US$2.1m	99.4%	no data
0.36%	Pale Fire Capital SE	221,875	US$1.7m	0%	0.12%
0.3%	Point72 Asset Management, L.P.	187,564	US$1.4m	6.67%	no data
0.3%	Qube Research & Technologies Ltd	182,738	US$1.4m	64.1%	no data
0.26%	Vanguard Fiduciary Trust Company	162,618	US$1.3m	0%	no data
0.24%	The Goldman Sachs Group, Inc.	151,127	US$1.2m	20%	no data
0.24%	FNY Investment Advisers, LLC	149,761	US$1.2m	4.82%	0.55%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/08 16:56
End of Day Share Price	2026/07/08 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sagimet Biosciences Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eliana Merle	Barclays
Edward Nash	Canaccord Genuity
Jonathan Wolleben	Citizens JMP Securities, LLC